5Friberg L, Hammar N, Pettersson H, et al. Increased mortality in paroxysmal atrial fibrillation:report from the Stockholm Cohort- Study of Atrial Fibrillation (SCAF)[J]. Eur Heart J, 2007, 28(19): 2346-2353.
6Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation:The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC) [J]. Eur Heart J, 2010, 31(19): 2369-2429.
2Camm AJ,Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC).Eur Heart J,2010,31(19):2369-2429.
3Wann LS,Curtis AB,January CT,et al.2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation(updating the 2006 guideline):a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation,2011,123(1):104-123.
4Lip GY,Nieuwlaat R,Pisters R,et al.Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach:the euro heart survey on atrial fibrillation.Chest,2010,137(2):263-272.
5Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation):developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.Circulation,2006,114(7):e257-354.
6Pisters R,Lane DA,Nieuwlaat R,et al.A novel user-friendly score(HAS-BLED)to assess 1-year risk of major bleeding in patients with atrial fibrillation:the Euro Heart Survey.Chest,2010,138(5):1093-1100.
7Lip GY,Frison L,Halperin JL,et al.Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation:the HAS-BLED(Hypertension,Abnormal Renal/Liver Function,Stroke,Bleeding History or Predisposition,Labile INR,Elderly,Drugs/Alcohol Concomitantly)score.J Am Coll Cardiol,2011,57(2):173-180.
8Mant J,Hobbs FD,Fletcher K,et al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation(the Birmingham Atrial Fibrillation Treatment of the Aged Study,BAFTA):a randomised controlled trial.Lancet,2007,370(9586):493-503.
9Guidelines for pharmacotherapy of atrial fibrillation(JCS 2008):digest version.Circ J,2010,74(11):2479-2500.
10Lip GY,Huber K,Andreotti F,et al.Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting.Thromb Haemost,2010,103(1):13-28.
